Objective: Basilic vein arteriovenous fistulas are an important and common option for hemodialysis access and require superficialization before use. Various superficialization techniques have been employed, such as basilic tunnel transposition (BTT), basilic elevation, and basilic elevation transposition (BET). Each technique may have advantages and disadvantages, and there have been few reports directly comparing the outcomes of these techniques. This report compares the clinical outcomes of BET vs BTT performed by a single operator and discusses some technical considerations derived from this study and the literature.
Basilic vein arteriovenous fistulas are commonly used for hemodialysis therapy and are one of the preferred access options according to the Kidney Disease Outcomes Quality Initiative and Society for Vascular Surgery guidelines when a standard arteriovenous fistula is not feasible. 1, 2 Upper arm basilic veins almost always require superficialization before use as they are located deep and are overlaid by the medial antebrachial cutaneous nerve. 2 However, a key issue after superficialization is the frequent development of basilic vein stenosis, especially in the proximal basilic vein swing segment. [3] [4] [5] [6] The clinical consequences of basilic vein stenosis are diverse and of significant clinical importance: insufficient access flow, bleeding, aneurysm formation, thrombosis, and even fistula loss. For management of these stenotic lesions, percutaneous or surgical interventions are usually required. [4] [5] [6] [7] The untransposed basilic fistula veins rarely develop stenosis. The mechanism of basilic vein stenosis after superficialization is uncertain but may be multifactorial: surgical trauma and ischemia due to dissection, torsion, and external tissue compressions with transposition; hemodynamic changes; patient characteristics; and trauma related to repeated fistula cannulations for hemodialysis. 4, 5, 7 Among these factors, surgical techniques may play a significant role in the subsequent development of basilic fistula vein stenosis. 3, [8] [9] [10] Various surgical techniques have been employed for superficialization of the basilic veins. 3, 8, 10 Typically, superficialization is accomplished by tunneling the transected basilic vein through a subcutaneous tunnel (basilic tunnel transposition [BTT] ). 2 However, BTT is frequently associated with stenosis at the area of transposition. A simpler approach is basilic elevation, relocating the basilic vein just beneath the incision. 5, 11 A drawback of simple elevation is that the fistula is cannulated through the incision scar, which may be less desirable for long-term fistula use 12 and more prone to subsequent complications. 11 elevation transposition (BET), in which the vein is elevated and positioned in a subcutaneous pocket anterior to the incision. 10, 13 With this approach, the basilic vein is not transected and is fully visualized in its new path, minimizing the likelihood of torsion or kinking. In addition, the basilic vein is positioned under healthy skin for cannulation. There have been few reports directly comparing the clinical outcomes of these techniques. 3, [9] [10] [11] 13 The clinical outcomes of BTT to the anterolateral position have been variable according to the literature 3, 9, 10, 14 and are more often associated with basilic vein stenosis in our experience. Based on our initial success with superficializing the deep cephalic fistula veins by the elevation transposition approach, we switched from the tunnel transposition approach to the elevation transposition approach for superficializing basilic fistula veins. This report compares the clinical outcomes of BET vs BTT performed by a single operator (S.W.) and discusses some technical considerations derived from this study and the literature.
METHODS
Setting and patients. This series included 99 patients who underwent second-stage basilic vein transposition from February 2009 to January 2016 in an ambulatory surgery center specialized in dialysis access care. Informed consent was obtained from patients before surgery. The Western Institutional Review Board (Puyallup, Wash) approved the study protocol. The author (S.W.) switched from BTT to BET in November 2010 and has been using BET ever since. This switch was based on his good clinical outcomes associated with use of the elevation transposition approach for superficializing deep cephalic fistula veins and suboptimal outcomes associated with BTT for superficializing basilic fistula veins. No other factors influenced the selection between BTT and BET.
Surgical procedures. All basilic vein transpositions were performed as second-stage procedures after the initial arteriovenous fistula creations and enlargement of the basilic veins (typically in 4-6 weeks). These surgeries were performed under conscious sedation (midazolam plus fentanyl) and local anesthesia (1% lidocaine). Prophylactic intravenous antibiotics (2 g cephazolin or 1 g vancomycin) were given preoperatively.
Duplex ultrasound examination was performed to evaluate the basilic vein and arterial anatomy and to mark major branches and the vessel pathways before transposition for surgical planning. It was also used before initial fistula creation, at 4 to 6 weeks after fistula creation, at 4 weeks after transposition, and in the subsequent surveillance follow-ups.
For BET, a single longitudinal incision was made over the basilic vein, and subcutaneous tissues were dissected to expose the basilic vein. The vein, including its proximal segment beyond the incision, was freed from the surrounding tissues. Special attention was given to protect the overlying medial antebrachial cutaneous nerve. The basilic vein could be transposed away from the nerve without entanglement in most cases. If the nerve branch entangled the basilic vein and impeded its anterior transposition, the nerve was carefully split between its major fascicles with blunt and sharp dissection to facilitate the transposition (Video, online only). Basilic vein tributaries and communicating branches with the brachial veins were clipped or ligated. A subcutaneous shelf anterior to the incision was created, and the basilic vein was elevated and secured in the subcutaneous position by approximating opposing soft tissues with nonabsorbable sutures (2-0 silk sutures). The subcutaneous tissues of the incision were approximated with absorbable sutures, and the incision was closed with absorbable subcuticular sutures or staples. For patients receiving antiplatelet or anticoagulation drugs, a Jackson-Pratt drain was placed before incision closure to minimize hematoma formation and removed in 24 to 72 hours after surgery (Fig 1) . 15 For BTT, the basilic vein was freed, marked with a marking pen to facilitate alignment during reanastomosis, transected distally, passed into an anterolateral subcutaneous tunnel with tunneling tools, and reanastomosed with the distal basilic vein in an end-to-end fashion. On occasion, when significant stenosis was identified in the juxta-anastomosis region, the basilic vein was reanastomosed to the brachial artery proximal to the initial anastomosis in an end-to-side fashion to bypass the stenosis. 15 Before reanastomosis, flush was insufficient to fully expand the transposed basilic vein. The basilic vein was then flushed with heparinized normal saline before the anastomosis was performed.
Follow-ups and interventions. After basilic transposition, the first visit was in 1 to 2 weeks to assess the incision healing. A duplex Doppler ultrasound evaluation, which included vein diameters, vein depth, flow volume, and presence or absence of any significant stenosis or aneurysm, was performed 4 weeks after transposition to confirm if a fistula was ready for cannulation. Further surveillance visits were scheduled at 4 and 10 months after transposition and at 6-to 12-month intervals afterward. For these surveillance visits, a combination of fistula-targeted history, physical examination, and ultrasound evaluation was employed. If a patient had no issues with using the fistula or other concerns and the physical examination revealed no abnormal findings, ultrasound evaluation could be omitted. Otherwise, duplex Doppler ultrasound evaluation was performed, which included the arterial inflow and venous outflow anatomies as well as the volume flow and hemodynamics of the fistula conduit. Shorter surveillance intervals might be needed for patients with clinical or image concerns.
The indications for fistulography and treatment of stenosis were based on a combination of clinical indicators and image study findings. The clinical indicators included reduced fistula flow, prolonged fistula bleeding after dialysis, fistula infiltration, elevated venous pressure, arm edema, fistula thrombosis, ischemic symptoms, and other clinical concerns. Interventions were performed for stenoses of >50% that were associated with clinical indicators. In this series, the interventions for stenoses were endovascular balloon angioplasties with occasional stent graft placements when indicated, and no surgical reanastomosis was employed. The indications for stent graft placement included rupture of vein during angioplasty, elastic stenosis with residual stenosis of >50% after balloon angioplasty, and recurrent stenosis that required balloon angioplasty in <3-month interval. These intervention indications and criteria were applied similarly to both BTT and BET groups.
Data collection and statistical analyses. Relevant clinical data were collected through retrospective review of the patients' medical records or prospective recording. Statistics were conducted using SPSS software version 23 (IBM Corp, Armonk, NY). Data were presented as mean 6 one standard deviation for continuous variables and as percentages or ratios for categorical variables.
Kaplan-Meier survival analysis was performed to estimate the fistula patency rates. 16 For the whole fistula conduit (including the vasculatures from the arteriovenous anastomosis to the right atrium), primary patency was defined as the interval from time of transposition surgery to any intervention designed to maintain the patency of the fistula or the time of patency measurement. Assisted primary patency was defined as the interval from time of transposition surgery to access thrombosis/abandonment or time of patency measurement, including endovascular interventions designed to maintain the functionality of a patent fistula. Secondary patency was defined as the interval from time of transposition surgery to access abandonment or time of patency measurement, including interventions designed to re-establish the functionality of a thrombosed fistula.
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To specifically assess the effect of the two transposition techniques, primary patency of the basilic vein segment that was transposed was determined by the definition described before and termed basilic vein primary patency. For basilic vein primary patency analysis, interventional events were limited to lesions within the vein segment that was transposed. The percutaneous interventions for lesions other than that of the transposed basilic vein, such as central vein stenosis, were excluded as they were not directly affected by the transposition surgeries. The patient's death and end of follow-up were censored for these analyses. The log-rank test was used to compare the cumulative patency curves between the BET and BTT groups. The number of percutaneous interventions (angioplasties) required per access-year was calculated by dividing the number of interventions for the basilic vein with the number of years of follow-up. For this calculation, the follow-up was limited to within 2 years after transpositions to minimize the difference in follow-up of the BET and BTT groups, and the interventions included only those for lesions of the basilic veins. The t-test was used to compare the average numbers of interventions per access-year of the BTT and BET groups. A two-tailed P < .05 was considered statistically significant for all the statistical analyses.
Cox proportional hazards regression analysis (Cox regression analysis) was used to assess the clinical factors that might affect the basilic vein primary patency.
RESULTS
The demographic and baseline characteristics of the 99 patients are listed in Table I as BTT and BET groups and combined. Of the 99 patients, 53% were male and 64% were diabetic; the mean age was 61 6 16 years; 27 had BTT and 72 had BET; the mean follow-up was 26.2 6 20.5 (range, 1-83) months. The number of patients who required a new arteriovenous anastomosis during basilic transposition was five in the BTT group and five in the BET group. The average time from transposition surgery to fistula cannulation was 34.7 6 16.7 days for the BTT group and 36.8 6 14.6 days for the BET group.
For the whole fistula conduits, the primary patency, assisted primary patency, and secondary patency rates were 26%, 91%, and 100% for the BTT group and 46%, 98%, 100% for the BET group at 1 year and 21%, 80%, 94% for the BTT group and 38%, 98%, 98% for the BET group at 2 years (Fig 2; Table II, a-d) . Of note, the primary failure rate after the first-stage upper arm basilic vein fistula creations was 6% (7/113) in our experience. Of these, three were clotted and abandoned, two were ligated for significant steal syndrome, and two were ligated for edema due to occluded central veins. Two patients had intraoperative dilator-assisted banding during secondstage basilic transposition for management of fistularelated steal syndrome. 17 The basilic vein primary patency rate was significantly lower for the BTT group vs the BET group (26% vs 61% at 1 year; 21% vs 55% at 2 years; P ¼ .006; Fig 2) . The average number of percutaneous angioplasties required for the basilic vein was significantly more for the BTT group vs the BET group (1.5 6 1.3 vs 0.6 6 1.0/access-year; P ¼ .007). To assess if other clinical factors might affect the basilic vein primary patency, a Cox regression analysis was performed. The factors included were surgical techniques (BTT vs BET), age, gender, body mass index, diabetes, hypertension, cardiovascular diseases, aspirin, clopidogrel, warfarin, and basilic vein diameter before fistula creation. The surgical techniques were the only factor that significantly affected the basilic vein primary patency (hazard ratio of 2.28 in favor of BET over BTT; 95% confidence interval, 1.25-4.14; P ¼ .007). During follow-up (1-83 months), all fistulas remained functional except one in the BTT group (abandoned after thrombosis as the patient was off dialysis after kidney transplantation) and one in the BET group (abandoned after thrombosis as the patient was on peritoneal dialysis).
During the early postoperative period (<30 days), a small percentage of patients developed relevant complications. In the BTT group, two patients had arm edema, one of whom was treated with antibiotics for presumptive cellulitis; one patient developed hematoma Kaplan-Meier survival analysis of the fistula circuits after basilic transposition. The cumulative patency curves shown are primary patency, assisted primary patency, and secondary patency of the whole fistula conduit separated as the basilic elevation transposition (BET) group (solid lines) and the basilic tunnel transposition (BTT) group (dotted lines). Basilic vein primary patency excluded interventions other than those for the basilic vein, such as interventions for the central veins that were not directly affected by the transposition surgeries. A P < .05 was considered statistically significant. that required surgical exploration; and three had self-referred hospitalizations (two related to the complications, one unrelated). In the BET group, five patients had arm edema, two of whom were treated with antibiotics for presumptive cellulitis; two patients had delayed incision healing, one of which was related to edema; one patient had incision abscess that required débridement; and six had self-referred hospitalizations (three related to the complications, three unrelated). Edema occurred often in both groups, and its possible contributors might include surgical trauma, ligation of the basilic vein tributaries, central vein stenosis, or other factors. All (1) 5 (2) 6 (5) 8 (4) 18 (12) 31 (21) Cases remaining, No. 
DISCUSSION
In this case series, we compared the clinical outcomes of two basilic vein transposition techniques: BTT and BET. We found that both BTT and BET could achieve high cumulative fistula patency rates despite needing repeated endovascular interventions in a subset of patients. BET was associated with improved basilic vein primary patency and reduced need for endovascular interventions compared with BTT. These data also demonstrate that these basilic vein transposition procedures can be safely performed in an outpatient surgery center under conscious sedation and local anesthesia, 18 and they are associated with an acceptable early postoperative complication profile. A major strength of this study is that all transposition procedures were performed by a single operator, eliminating the interoperator variation that might affect surgical outcomes. This strengthens the direct comparison of the two surgical techniques. Study limitations include the retrospective nature of the case series, the nonrandomized comparison, limited and unequal sample sizes, and potential variation in decisions for endovascular interventions. Given these limitations, further clinical data are needed to support that BET improves the clinical outcomes of basilic vein superficialization. How tunneling is performed and the pathway chosen may substantially affect the clinical outcomes of BTT. Basilic vein harvest through segmental small incisions with tunneling subcutaneously in locations similar to the original basilic veins 19 or slightly anteriorly 20 yields very good clinical outcomes. 19, 20 These reports along with our experience and data support the notion that reducing angulation and torsion may improve the clinical outcomes of basilic transposition. More anterolateral tunneling was employed for the BTT group in our series, which might have contributed to the more frequent development of basilic vein stenosis due to increased angulation and torsion. Although the Fogarty balloon could help expand a transposed basilic vein, its use in some patients of the BTT group could also potentially cause some intimal damage and contribute to the subsequent stenosis. It has been reported that there is substantial variation of the basilic vein anatomy in the upper arm. Up to 34% the patients have basilic vein joining the brachial vein in the middle or lower portion of the upper arm. 21 Variation in the arterial anatomy may also affect the success of basilic fistulas.
3 Therefore, duplex ultrasound is needed to understand the basilic vein and arterial anatomy in the upper extremity before a basilic vein fistula is created. It may be futile to create a basilic or brachial vein fistula that does not have enough quality length for transposition. Despite the variations in basilic vein anatomy, good clinical success can still be achieved by transposing the basilic vein in continuity with the brachial vein or brachial vein alone based on the experience of one of the authors (W.C.J.) and others. 22, 23 Fistula inflow (juxta-anastomosis) stenosis may occur in some patients after initial creation of basilic fistulas. To minimize the need of future interventions for this area, a new arteriovenous anastomosis may be created to eliminate the flow-limiting inflow segment during the second-stage transposition surgery. This strategy was employed in 10 patients in our series. Good clinical outcomes were achieved when new arteriovenous anastomosis was routinely created during second-stage transposition based on a report of 49 patients. 24 In our opinion, a new arteriovenous anastomosis is helpful only when there is flow-limiting inflow stenosis, which affects only a small percentage of patients. The medial antebrachial cutaneous nerve usually accompanies the basilic vein along its path in the upper arm. The basilic vein usually can be transposed away from the nerve without entanglement. If the nerve branch entangles the basilic vein and impedes its anterior transposition, the nerve may be carefully split along its fascicles with blunt and sharp dissection to facilitate basilic vein elevation without causing significant nerve defect based on our experience and a recent report by others. 25 If mild to moderate steal syndrome develops after a first-stage basilic fistula creation and excessive fistula flow is confirmed (such as with duplex Doppler ultrasound), dilator-assisted banding may be employed to limit fistula flow before or during second-stage basilic transposition as done in two patients in this series. Dilator-assisted banding is a simple and effective guided fistula flow reduction approach that we described previously. 17, 26, 27 The reported clinical outcomes of basilic vein transposition vary widely in the literature. 3, [8] [9] [10] 14 The definitions and calculations of the fistula patency rates in the reports differed significantly. 3, 10, 14 Furthermore, the primary failure rates after initial basilic vein fistula creation also vary widely in the range of 5% to 45%. The subsequent calculation of fistula patency rates after basilic transposition in these reports did not take into account these primary failures. Therefore, caution is needed in interpreting the outcomes of the published reports. 3, 10, 14 The clinical outcomes of basilic fistulas may be influenced by many factors that may include patient characteristics, surgical expertise, access surveillance, use of endovascular and surgical interventions, technical abilities of the hemodialysis staff, and other factors. 3, 10 Overall, the basilic fistulas provide better outcomes than prosthetic arteriovenous grafts. 3, 10, 28 Whether one-stage transposition and creation or two-stage creation, then transposition is preferred remains controversial and largely a matter of preference of the operating surgeons. 3, [8] [9] [10] 14 An advantage of the one-stage approach is that the fistula may be usable sooner after initial surgery than in the two-stage approach, which requires several more weeks wait time before the second-stage transposition. According to two meta-analyses of retrospective and prospective reports, one-stage and two-stage approaches are associated with comparable clinical outcomes. 9, 14 However, when the native basilic veins are smaller (<4 mm in diameter), the two-stage approach was preferred in most reports. 3, [8] [9] [10] 14, 22 Therefore, the comparison of onestage and two-stage approaches in many reports was biased. 3, [8] [9] [10] 14 A recent randomized controlled study was prematurely terminated because of clear superiority of the two-stage approach. 29 Percutaneous or surgical interventions are needed for maintaining the patency and managing complications of basilic fistulas, but their use varies widely in the published reports. 3, 7, 14 These interventions reduce the primary patency but are needed to promote the long-term survival of the fistulas. Access surveillance with regular physical examination and as-needed ultrasound examination may identify lesions before they cause more serious access events, such as thrombosis and fistula loss. If significant lesions or issues are identified, a timely intervention may significantly reduce the risk of more serious access events and therefore enhance the survival of these accesses. 1, 2, 7, 30 Our results of high secondary patency rate may be the result of this surveillance strategy.
BET may offer some advantages: it is easier to learn and faster to perform, and it potentially has better clinical outcomes. The technical inconsistency of basilic transposition may be minimized with BET, resulting in more consistent outcomes. Unlike with basilic elevation, minor incision issues will not affect fistula cannulation. A drawback of BET is that the basilic vein is usually still located medially in the upper arm, a location that may affect the ease of cannulation. According to a report that surveyed the dialysis staff, the BTTs positioned more anteriorly had a higher staff satisfaction rate than the fistulas that were elevated. 11 Fortunately, a simple maneuver of pushing the posterior soft tissue with a hand will make the fistula front-center. As an advantage, the medial location of a fistula renders it less visible, which may be favored cosmetically by patients. A word of caution: BET may be difficult or impossible to perform in patients with very thin skin and subcutaneous tissues.
CONCLUSIONS
BET is a reliable approach that yields a high cumulative fistula survival rate. Compared with BTT, BET is associated with improved basilic vein primary patency and reduced need for endovascular interventions. Based on our experience and the literature, some technical considerations were discussed that may help improve the outcomes of basilic vein fistulas (Table III) . Further data and research are needed to confirm the advantages of the BET approach.
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